Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Gradman

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Yale Journal of Biology and Medicine|May 1, 1980
High dose propranolol in the treatment of angina pectoris: relationship of dose to blood levels and hemodynamic consequencesR A Zito, I Cassell, M Cunningham, et al.
International Journal of Clinical Practice|June 26, 2007
Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertensionJ Nussberger, A H Gradman, R E Schmieder, et al.
American Journal of Hypertension|July 20, 1999
Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study GroupW J Elliott, R Montoro, D Smith, et al.
American Journal of Hypertension|June 2, 1998
A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's GroupY Lacourcière, J L Pool, L Svetkey, et al.
The American Journal of Cardiology|February 15, 1997
Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study GroupA H Gradman, N R Cutler, P J Davis, et al.
Circulation|May 1, 1977
Suppression of premature ventricular contractions by acebutololA H Gradman, R A Winkle, J W Fitzgerald, et al.
Clinical Therapeutics|July 15, 1998
Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study GroupA H Gradman, N R Cutler, P J Davis, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1995
A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertensionA H Gradman, K E Arcuri, A I Goldberg, et al.
American Heart Journal|June 1, 1993
Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertensionJ L Mehta, L M Lopez, N D Vlachakis, et al.
Heart Disease (Hagerstown, Md.)|November 27, 2001
Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study GroupA H Gradman, A Lewin, B T Bowling, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Yale Journal of Biology and Medicine|May 1, 1980
High dose propranolol in the treatment of angina pectoris: relationship of dose to blood levels and hemodynamic consequencesR A Zito, I Cassell, M Cunningham, et al.
International Journal of Clinical Practice|June 26, 2007
Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertensionJ Nussberger, A H Gradman, R E Schmieder, et al.
American Journal of Hypertension|July 20, 1999
Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study GroupW J Elliott, R Montoro, D Smith, et al.
American Journal of Hypertension|June 2, 1998
A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's GroupY Lacourcière, J L Pool, L Svetkey, et al.
The American Journal of Cardiology|February 15, 1997
Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study GroupA H Gradman, N R Cutler, P J Davis, et al.
Circulation|May 1, 1977
Suppression of premature ventricular contractions by acebutololA H Gradman, R A Winkle, J W Fitzgerald, et al.
Clinical Therapeutics|July 15, 1998
Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study GroupA H Gradman, N R Cutler, P J Davis, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1995
A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertensionA H Gradman, K E Arcuri, A I Goldberg, et al.
American Heart Journal|June 1, 1993
Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertensionJ L Mehta, L M Lopez, N D Vlachakis, et al.
Heart Disease (Hagerstown, Md.)|November 27, 2001
Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study GroupA H Gradman, A Lewin, B T Bowling, et al.
Pageof 4